BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16571082)

  • 1. Regulation of nuclear coactivator and corepressor expression in mouse cerebellum by thyroid hormone.
    Ramos HE; Weiss RE
    Thyroid; 2006 Mar; 16(3):211-6. PubMed ID: 16571082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.
    Martinez de Arrieta C; Koibuchi N; Chin WW
    Endocrinology; 2000 May; 141(5):1693-8. PubMed ID: 10803578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action.
    Sadow PM; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Weiss RE
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E36-46. PubMed ID: 12388168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary.
    Sadow PM; Koo E; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Seo H; Murata Y; Weiss RE
    Mol Endocrinol; 2003 May; 17(5):882-94. PubMed ID: 12576486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of expression of thyroid hormone receptor isoforms and coactivators in liver and heart by thyroid hormone.
    Sadow PM; Chassande O; Koo EK; Gauthier K; Samarut J; Xu J; O'Malley BW; Weiss RE
    Mol Cell Endocrinol; 2003 May; 203(1-2):65-75. PubMed ID: 12782404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
    Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
    Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
    Loinder K; Söderström M
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice.
    Alonso M; Goodwin C; Liao X; Ortiga-Carvalho T; Machado DS; Wondisford FE; Refetoff S; Weiss RE
    Endocrinology; 2009 Aug; 150(8):3927-34. PubMed ID: 19406944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
    Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
    Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface.
    Ortiga-Carvalho TM; Shibusawa N; Nikrodhanond A; Oliveira KJ; Machado DS; Liao XH; Cohen RN; Refetoff S; Wondisford FE
    J Clin Invest; 2005 Sep; 115(9):2517-23. PubMed ID: 16100573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone.
    Weiss RE; Xu J; Ning G; Pohlenz J; O'Malley BW; Refetoff S
    EMBO J; 1999 Apr; 18(7):1900-4. PubMed ID: 10202153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
    Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
    Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
    Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
    J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
    Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
    J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene.
    van der Laan S; Lachize SB; Vreugdenhil E; de Kloet ER; Meijer OC
    Endocrinology; 2008 Feb; 149(2):725-32. PubMed ID: 18006628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptor coactivator-1 deficiency causes variable alterations in the modulation of T(3)-regulated transcription of genes in vivo.
    Takeuchi Y; Murata Y; Sadow P; Hayashi Y; Seo H; Xu J; O'Malley BW; Weiss RE; Refetoff S
    Endocrinology; 2002 Apr; 143(4):1346-52. PubMed ID: 11897691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
    Tagami T; Lutz WH; Kumar R; Jameson JL
    Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors.
    Liu Y; Takeshita A; Misiti S; Chin WW; Yen PM
    Endocrinology; 1998 Oct; 139(10):4197-204. PubMed ID: 9751500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.